Risk of hepatotoxicity in virologically suppressed HIV patients switching to nevirapine according to gender and CD4 count

被引：0
|
作者：
De Lazzari, E. [1 ]
Leon, A. [1 ]
Arnaiz, J. A. [1 ]
Martinez, E. [1 ]
Mallolas, J. M. [1 ]
Blanco, J. L. [1 ]
Laguno, M. [1 ]
Larrousse, M. [1 ]
Milinkovic, A. [1 ]
Lonca, M. [1 ]
Gatell, J. M. [1 ]
机构：
[1] Univ Barcelona, Barcelona, Spain
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：L8 / L8
页数：1
相关论文
共 50 条
  • [21] The Efficacy, Pharmacokinetics, and Safety of a Nevirapine to Rilpivirine Switch in Virologically Suppressed HIV-1-Infected Patients
    Rokx, Casper
    Blonk, Maren
    Verbon, Annelies
    Burger, David
    Rijnders, Bart J. A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (01) : 36 - 39
  • [22] CD4 count/viral load in HIV
    Hengel, R
    CYTOMETRY, 2000, 42 (01): : 79 - 80
  • [23] Predisposing factors for nevirapine toxicity among AIDS patients with low baseline CD4 count
    Tansuphaswadikul, Somsit
    Aung, Saw Eindani
    Phonrat, Benjaluck
    Kaewkungwal, Jaranit
    Pitisuftithum, Punnee
    Maek-a-Nantawat, Wirach
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2007, 25 (2-3): : 147 - 154
  • [24] Predisposing factors for nevirapine toxicity among AIDS patients with low baseline CD4 count
    Maek-a-nantawat, W.
    Tansuphaswadikul, S.
    Aung, S.
    Phonrat, B.
    Kaewkungwal, J.
    Pitisuttithum, P.
    ALLERGY, 2007, 62 : 160 - 160
  • [25] CD4/CD8 Ratio Predicts Yellow Fever Vaccine-Induced Antibody Titers in Virologically Suppressed HIV-Infected Patients
    Avelino-Silva, Vivian Iida
    Miyaji, Karina Takesaki
    Mathias, Augusto
    Costa, Dayane Alves
    de Carvalho Dias, Juliana Zanatta
    Lima, Sheila Barbosa
    Simoes, Marisol
    Freire, Marcos S.
    Caiaffa-Filho, Helio H.
    Hong, Marisa A.
    Lopes, Marta H.
    Sartori, Ana M.
    Kallas, Esper G.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (02) : 189 - 195
  • [26] The Interaction of CD4 T-Cell Count and Nevirapine Hepatotoxicity in China: A Change in National Treatment Guidelines May Be Warranted
    Zhang, Chengda
    Wang, Wei
    Zhou, Mengyu
    Han, Yang
    Xie, Jing
    Qiu, Zhifeng
    Guo, Fuping
    Li, Yanling
    Wang, Huanling
    Ghanem, Khalil G.
    Li, Taisheng
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (05) : 540 - 545
  • [27] PINCH levels in the CSF of HIV patients correlate with CD4 count
    Langford, Dianne
    Adiga, R.
    Ozdemir, A. Y.
    Carides, A.
    Wasilewski, M.
    Yen, W.
    Chitturi, P.
    Ellis, R.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2014, 9 (01) : 30 - 30
  • [28] Effect of CD4 Count on the Etiology of Esophageal Disease in HIV Patients
    Woolard, Shani
    Qayed, Emad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S216 - S217
  • [29] Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya
    Peters, P. J.
    Stringer, J.
    McConnell, M. S.
    Kiarie, J.
    Ratanasuwan, W.
    Intalapaporn, P.
    Potter, D.
    Mutsotso, W.
    Zulu, I.
    Borkowf, C. B.
    Bolu, O.
    Brooks, J. T.
    Weidle, P. J.
    HIV MEDICINE, 2010, 11 (10) : 650 - 660
  • [30] CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis
    Ford, Nathan
    Stinson, Kathryn
    Gale, Howard
    Mills, Edward J.
    Stevens, Wendy
    Gonzalez, Mercedes P.
    Markby, Jessica
    Hill, Andrew
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18
12345